Search results
1 lip 2020 · Antibiotics which may be considered to treat E. coli infections include amoxicillin, as well as other semisynthetic penicillins, many cephalosporins, diverse combinations of beta-lactams with beta-lactamase inhibitors, carbapenems, aztreonam, fluoroquinolones, tigecycline, aminoglycosides, trimethoprim-sulfamethoxazole, nitrofurantoin ...
13 lip 2023 · In general, extraintestinal infections caused by E. coli are susceptible to a variety of antibiotics, as listed below. E. coli can harbor genes for antibiotic resistance, and antibiotic therapy targeting these organisms must be tailored.
24 cze 2024 · Diarrheagenic E. coli are among the most frequent bacterial causes of gastroenteritis worldwide. The most common diarrheagenic clones can be assigned to specific pathotypes, which have distinct pathogenic, epidemiologic, and clinical characteristics (table 1) [1].
25 sty 2021 · Recently, a new pathotype called adherent-invasive E. coli (AIEC) has been proposed as being associated with inflammatory bowel disease, especially Crohn’s disease. As Gram-negative organisms, E. coli are resistant to many antibiotics, and high-risk E. coli multiresistant clones are emerging.
Abstract. Escherichia coli remains one of the most frequent causes of nosocomial and community-acquired bacterial infections including urinary tract infections, enteric infections and systemic infections in humans.
21 gru 2020 · Here, we briefly revisited the details of these E. coli classic and hybrid pathogens, the increase in antimicrobial resistance in the context of a genetically empowered multifaceted and versatile bug and the growing need to advance alternative therapies to fight these infections.
SUMMARY. Although Escherichia coli can be an innocuous resident of the gastrointestinal tract, it also has the pathogenic capacity to cause significant diarrheal and extraintestinal diseases. Pathogenic variants of E. coli (pathovars or pathotypes) cause much morbidity and mortality worldwide.
